[1]
“Potential pharmacological approach in the regulation of angiotensin-II conversion enzyme and dipeptidyl-peptidase 4 in diabetic COVID-19 patients”, Ital J Med, vol. 15, no. 1, Dec. 2020, doi: 10.4081/itjm.2020.1435.